Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sorin unveils 37-Joules defibrillator

This article was originally published in The Gray Sheet

Executive Summary

Sorin Group is expanding its U.S. sales organization to market Paradym CRT Model 8750, a next-generation implantable defibrillator for management of cardiac resynchronization and anti-tachyarrhythmia therapy in heart failure patients, the firm announced earlier this month. FDA approved a supplemental PMA for the device on Oct. 27. Paradym delivers 37 Joules of energy, the highest of any implantable ICD, Sorin claims. The firm has sold the device in Europe since 2008, and is awaiting regulatory approval in Japan
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT028508

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel